The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Linda56

Topics Engaged In

Viewing 6 topics - 1 through 6 (of 6 total)

- TOPIC
- Another Round of Good News
  Started by: Richard_K General Melanoma Community
- 4
- 4
- sing123
  
  4 years ago
- Zelboraf long time user
  Started by: Kopetz General Melanoma Community
- 4
- 12
- Bruce Davis
  
  10 years, 1 month ago
- easy to understand info about how immunotherapy works
  Started by: yazziemac General Melanoma Community
- 3
- 9
- Linda56
  
  10 years, 5 months ago
- Update on treatment with Zelboraf/Tafinlar – NED again after 28 months
  Started by: Linda56 General Melanoma Community
- 2
- 9
- Linda56
  
  10 years, 6 months ago
- Vemurafenib
  Started by: cornishman32 General Melanoma Community
- 5
- 15
- KYDonna
  
  11 years, 4 months ago
- Side effects with Zelboraf
  Started by: Linda56 General Melanoma Community
- 6
- 30
- Linda56
  
  11 years, 7 months ago

Viewing 6 topics - 1 through 6 (of 6 total)

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.